MARKET

AZN

AZN

Astrazeneca Plc
NASDAQ
91.22
-0.35
-0.38%
Pre Market: 92.44 +1.22 +1.34% 08:50 01/06 EST
OPEN
91.17
PREV CLOSE
91.57
HIGH
91.38
LOW
89.53
VOLUME
21.25K
TURNOVER
0
52 WEEK HIGH
94.02
52 WEEK LOW
60.82
MARKET CAP
282.95B
P/E (TTM)
30.31
1D
5D
1M
3M
1Y
5Y
1D
J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)
TipRanks · 7h ago
AstraZeneca announces results of Saphnelo were statistically significant
TipRanks · 8h ago
AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial
Benzinga · 8h ago
Heard on the Street: Big Pharma Has More Going for It Than Obesity Drugs
The Wall Street Journal · 9h ago
AstraZeneca's Full Data From Phase 3 Tulip-SC Trial Show That Subcutaneous Saphnelo (Anifrolumab) Demonstrated a Statistically Significant and Clinically Meaningful Reduction in Disease Activity Vs. Placebo in Systemic Lupus Erythematosus Patients
Benzinga · 11h ago
BRIEF-Astrazeneca Says Saphnelo SC Showed Significant Reduction In Lupus Disease Activity
Reuters · 12h ago
Kennedy scales back number of vaccines recommended for children, NYT says
TipRanks · 1d ago
AstraZeneca removed from European Conviction List at Goldman Sachs
TipRanks · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (ADR) stock information, including NASDAQ: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.